UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001667
Receipt number R000002017
Scientific Title Genetic diagnosis of factor V deficiency
Date of disclosure of the study information 2009/02/01
Last modified on 2012/07/30 11:09:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Genetic diagnosis of factor V deficiency

Acronym

Factor V gene

Scientific Title

Genetic diagnosis of factor V deficiency

Scientific Title:Acronym

Factor V gene

Region

Japan


Condition

Condition

Factor V deficiency

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Identify genetic abnormalities of the factor V gene in the patients with factor V deficiency

Basic objectives2

Others

Basic objectives -Others

Predict the amino acid sequences based on the identified genetic variants

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identify genetic variants different from the normal sequences of the factor V gene

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are diagnosed as factor V deficiency by general examinations

Key exclusion criteria

not particular

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenji Izuhara

Organization

Saga Medical School

Division name

Division of Medical Chemistry, Department of Biomolecular Sciences

Zip code


Address

5-1-1, Nabeshima, Saga

TEL

0952-34-2261

Email



Public contact

Name of contact person

1st name
Middle name
Last name Setsuko Sunami

Organization

Saga Medical School

Division name

Department of Service for Patients

Zip code


Address

5-1-1, Nabeshima, Saga

TEL

0952-34-3137

Homepage URL


Email

sunamis@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga Medical School Hospital

Institute

Department

Personal name



Funding Source

Organization

Saga Medical School Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

We analyzed 5 patients and 2 families during the past three and half years.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 08 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 07 Month 31 Day

Date trial data considered complete

2012 Year 07 Month 31 Day

Date analysis concluded

2012 Year 07 Month 31 Day


Other

Other related information

All of the identified variants were novel missense mutants.


Management information

Registered date

2009 Year 01 Month 29 Day

Last modified on

2012 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002017


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name